Soft gelatin capsules are oral dosage forms designed to enclose liquid, semi-solid, or other suitable formulations within a flexible gelatin shell. They are used across pharmaceutical, nutraceutical, vitamin, and health-product applications because their format can support convenient administration and protect encapsulated ingredients. In the United Kingdom, pharmaceutical development, demand for convenient dosage formats, and continued investment in formulation technologies are supporting the use of soft gelatin capsules.

A recent study by MarkNtel Advisors highlights that the United Kingdom soft gelatin capsules sector was valued at USD 275 million in 2025. It is projected to grow from USD 290.95 million in 2026 to USD 408.07 million by 2032, registering a CAGR of 5.8% during 2026–2032. Gelatin soft capsules represented about 78% of the product type segment in 2026, demonstrating the continued importance of conventional gelatin-based capsule technologies in the country.

Gelatin Soft Capsules Maintain Strong Adoption

Gelatin soft capsules remain widely used because their flexible shell can accommodate liquid and semi-solid fills. Research on oral drug delivery identifies soft gelatin capsules as a dosage format commonly used for liquid-fill and semi-solid formulations, including certain pharmaceutical and vitamin products.

The format provides manufacturers with flexibility when developing products requiring encapsulation of suitable active ingredients, oils, solutions, or suspensions. This versatility supports applications across pharmaceutical and nutritional product categories.

Pharmaceutical Formulations Support Demand

Pharmaceutical applications represent an important area for soft gelatin capsule consumption. Certain active ingredients can be formulated within soft capsules when the dosage form is compatible with the ingredient's physical and chemical characteristics.

Soft gelatin capsules are also being investigated for formulations involving poorly water-soluble compounds. Research indicates that these dosage forms can provide formulation opportunities for certain compounds where dissolution and delivery present technical challenges.

This makes formulation development, stability assessment, and appropriate dissolution testing important considerations for manufacturers.

Nutraceutical Products Expand Application Opportunities

Soft gelatin capsules are widely associated with vitamins, nutritional products, oils, and other health-oriented formulations. Their convenient format can support products containing ingredients that are suitable for liquid or semi-solid encapsulation.

Growing interest in wellness and preventive health products is creating opportunities for manufacturers to develop differentiated capsule formulations. Product characteristics such as capsule size, fill composition, appearance, and ease of administration can influence consumer preferences.

Manufacturing Technology Improves Production

Advances in encapsulation equipment and manufacturing processes are helping producers improve consistency, filling accuracy, sealing, and production efficiency. Modern production systems are designed to handle high-volume manufacturing while maintaining quality requirements.

Manufacturers are also focusing on shell composition, fill compatibility, drying conditions, and storage stability. These factors can influence the physical performance and shelf life of finished soft gelatin capsules.

Quality Control Remains Essential

Quality control is particularly important for capsule products because both the shell and internal formulation must meet defined specifications. Manufacturers need to assess characteristics such as capsule integrity, fill weight, appearance, stability, and dissolution performance where applicable.

The Medicines and Healthcare products Regulatory Agency (MHRA) provides access to information concerning medicines, including product characteristics, patient information leaflets, and scientific reports. Such regulatory requirements support the broader need for consistent quality and appropriate product information in pharmaceutical manufacturing.

Regulatory Standards Influence Product Development

Regulatory compliance is an important factor for pharmaceutical capsule manufacturers operating in the United Kingdom. Licensed medicines must meet requirements covering quality, safety, product information, packaging, and labelling.

The MHRA guidance on medicine packaging and labelling outlines requirements concerning medicine packaging and the information supplied to patients and healthcare professionals.

These requirements encourage manufacturers to maintain strong quality systems and carefully manage product information throughout the development and commercialization process.

Formulation Innovation Creates New Opportunities

Researchers and manufacturers continue exploring improved capsule technologies to address formulation challenges. Soft gelatin capsules can be useful for liquid and semi-solid fills, while formulation scientists continue examining materials, excipients, and processing techniques that influence capsule performance.

Research into soft gelatin capsule dissolution also highlights the importance of formulation composition and gelatin properties when evaluating product performance. These considerations encourage manufacturers to optimize both shell and fill characteristics during product development.

Supply Chain and Ingredient Quality Matter

The performance of soft gelatin capsules depends partly on the quality and consistency of raw materials used during production. Gelatin characteristics, plasticizers, water content, active ingredients, and other formulation components can affect manufacturing and finished-product properties.

Manufacturers therefore need reliable supply chains and quality-control systems to maintain consistency between production batches. Effective sourcing and testing practices can help support stable manufacturing operations.

Sustainability Gains Attention

Sustainability is becoming an increasingly relevant consideration across pharmaceutical and health-product manufacturing. Companies are examining production efficiency, material use, packaging, energy consumption, and waste management as part of broader environmental objectives.

For capsule manufacturers, opportunities may include improving manufacturing efficiency, optimizing material usage, and evaluating packaging solutions that reduce unnecessary resource consumption while maintaining product protection and regulatory requirements.

Challenges Influence Capsule Development

The United Kingdom soft gelatin capsules sector faces challenges related to formulation compatibility, manufacturing complexity, raw-material quality, regulatory requirements, and production costs. Manufacturers must maintain consistent capsule performance while meeting increasingly detailed quality and compliance expectations.

Product development can also require careful evaluation of dissolution, stability, and interactions between the capsule shell and fill formulation. Addressing these technical considerations is important for reliable commercialization.

Innovation Shapes Future Capsule Growth

The United Kingdom soft gelatin capsules sector is evolving through pharmaceutical formulation development, nutraceutical demand, manufacturing improvements, quality requirements, and advances in oral dosage technologies. The projected increase from USD 290.95 million in 2026 to USD 408.07 million by 2032 reflects continued demand for convenient and versatile encapsulation formats.

Future development will remain connected with improved manufacturing systems, specialized formulations, quality control, regulatory compliance, and innovation in capsule materials. As pharmaceutical and health-product manufacturers continue seeking efficient oral dosage solutions, soft gelatin capsules are expected to maintain an important role in the United Kingdom's formulation landscape.